🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the platform has removed violative material and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at residence.

Within moments of joining one group, a vendor posted WhatsApp details, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Within these communities, messages show dark colored packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant health risks”.